{"id":"https://genegraph.clinicalgenome.org/r/1b276bd7-5045-4df1-9c31-4d4c8dcdcd4av1.0","type":"EvidenceStrengthAssertion","dc:description":"There has been sufficient amount of evidence published associating the RUNX1 gene with familial platelet disorder with associated myeloid malignancy (FPDMM) since the gene-disease relationship was first proposed by Song et al. (1999). Plenty of case level studies have been performed with FPDMM patients that have variants in the RUNX1 gene. RUNX1 has a primary role in the development of all hematopoietic cell types and RUNX1 is shown to express in hematopoietic lineages and peripheral lymphocytes. CBFB, the beta subunit forming the same transcriptional complex, is also associated with somatic acute myeloid leukemia. Megakaryocyte colony formation decreased in patient cells and targeted correction of RUNX1 rescue megakaryopoietic defects. Thrombocytopenia and megakaryocytic maturation arrest are reported in induced RUNX1 knockout mice. All of these evidences suggest a definitive relationship between the RUNX1 gene and familial platelet disorder with associated myeloid malignancy (FPDMM).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1b276bd7-5045-4df1-9c31-4d4c8dcdcd4a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-06-04T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"The maximum Segregation points for target sequencing should be 1.5 not 3, but total LOD score for RUNX1 is very high and can consider increase points.  Also, the first well studied family with 29 affected members carrying unsertein large deletion.  It can also be scored but not allowed in this system.  Therefore, it is reasonable the total points of genetic evidence is 12.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a207df0b-5a74-4b99-84a5-1a1448a0c4e4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03046077-f812-4f7b-b9ea-4c2125849204","type":"Finding","dc:description":"Thrombocytopenia and megakaryocytic maturation arrest of induced AML-1 knockout mice (Figure 2). Hematopoietic progenitor cells are expanded in floxed bone marrow (Figure 3). RUNX1 is required in lymphoid precursors committed to T- or B-cell lineages (Figure 4).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14966519","rdfs:label":"AML1 in megakaryocytic maturation and thrombocytopenia","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/11b4a5d9-47ad-437e-aec7-d2434e0599c4","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d88987d8-ae30-4285-af83-46d157cc6b3b","type":"Finding","dc:description":"The 2 mutation-corrected iPSC lines produced ~40% to 60% more CD41+ CD42+ MKs than the patient and the wild-type allele-targeted iPSC lines at both time points (Figure 2B-D and supplemental Table 5).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25114263","rdfs:label":"Targeted correction of RUNX1 rescue megakaryopoietic defects","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba79e85c-61b7-4bb0-9e0d-075a03ad7f81","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16d61918-f864-4ca4-a679-da0bcc2f8bac","type":"FunctionalAlteration","dc:description":"There was a substantial decrease in megakaryocyte colony formation in affected individuals compared with controls (Table 1)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"Haematopoietic colony-forming units in FDP/AML individuals"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c199bdd1-7ee5-4ef9-a5eb-e06151b9753c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/334215e3-36b7-44b2-928a-6a464ce05b49","type":"Finding","dc:description":"Runx1 is required for progression of CD41+embryonic precursors into HSCs. (Figure 1 and Figure 2).  RUNX1 has a primary role in the development of all hematopoietic cell types (definitive erythroid cells, granulocytes, macrophages, and lymphoid cells);","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25139854","rdfs:label":"RUNX1 function in the development of hematopoietic cells","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bb6e4410-b210-47c1-8a56-f985cecc31d4","type":"EvidenceLine","dc:description":"Consider reduce points because RUNX1 is more well stablished for FPD/AML than CBFB and no inherited variant found yet for CBFB.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b6490fd-38f0-405d-85fc-b4063f0574fd","type":"Finding","dc:description":"RUNX1 and CBFB are two subunits forming the same transcriptional complex showing in the co-crystal structure. (Figure 2 and Figure 5).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10856244","rdfs:label":"CBFB is associated with acute myeloid leukemia","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/410622e2-7cc9-47a7-9884-f538321cf04d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3da14c6f-05c4-4ff1-a930-315d1b3ea67a","type":"Finding","dc:description":"Expression of Runx1 in hematopoietic lineages. Expression of Runx1 in peripheral lymphocytes. (Figure 2,3,5)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14630789","rdfs:label":"Expression of Runx1 in hematopoietic lineages","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5},{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8441219-4914-47b6-8e59-7a1226943b17_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 1-bp deletion in the splice donor site of intron 4 of the RUNX1 gene (IVS4+3delA). The novel transcript resulting from use of a cryptic donor site resulted in frameshift after amino acid 135, addition of 41 unrelated residues, and termination at codon 177 (Arg135fsTer177).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c93f1c1-c4e3-4aa3-a18e-8752418f814c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11830488","rdfs:label":"pedigree 2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"All 9 exons of RUNX1 were amplified from genomic DNA using primers designed to the flanking region of each exon.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001873","obo:HP_0002863","obo:HP_0003540","obo:HP_0004808"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f8441219-4914-47b6-8e59-7a1226943b17_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11830488","allele":{"id":"https://genegraph.clinicalgenome.org/r/4ebb23d5-ec0b-4d82-b4df-f53b9b155514","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001754.4(RUNX1):c.508+3delA","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/14466"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0ed3d5a2-75a2-48eb-bb20-8253b4742ab3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A nonsense mutation at amino acid 204 near the 3 ́ end of CBFA2 exon 5.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e89eb9d-65d5-4820-a2a1-102bc3b9e2f4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Direct sequence analysis of exons 1–8 amplified from genomic DNA","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001873","obo:HP_0003540","obo:HP_0002863","obo:HP_0004808"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/0ed3d5a2-75a2-48eb-bb20-8253b4742ab3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","allele":{"id":"https://genegraph.clinicalgenome.org/r/af8ef221-76de-42b3-9cc6-0437adb105fb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000021.9:g.34859477G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410207940"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1dd64a86-14a9-436c-a80d-7eb8e0d6e787_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Affected individuals had a heterozygous G-to-T transversion in the splice acceptor site in the last nucleotide of intron 3. The change enforced the use of a cryptic splice acceptor in exon 4 with a resultant frameshift causing a stop codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04dbb86e-2470-46ba-a353-7b03f9d2e761","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Direct sequence analysis of exons 1–8 amplified fromgenomic DNA","firstTestingMethod":"PCR","phenotypes":["obo:HP_0004808","obo:HP_0002863","obo:HP_0001873","obo:HP_0003540"],"previousTesting":true,"previousTestingDescription":"PMID: 9746808","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1dd64a86-14a9-436c-a80d-7eb8e0d6e787_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4d977ee-68da-464f-84a7-0dbe2be95d91","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001754.4(RUNX1):c.352-1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/14463"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/738fe746-3518-4830-8137-f29473d7e1a9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A heterozygous C-to-A transversion in exon 7B of the RUNX1 gene, resulting in atyr260-to-ter (Y260X) substitution.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7545ecc5-13f8-4c70-8dd1-34a7c547a56a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11830488","rdfs:label":"pedigree 3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"All 9 exons of RUNX1 were amplified from genomic DNA using primers designed to the flanking region of each exon.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001873","obo:HP_0003540","obo:HP_0004808","obo:HP_0002863"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/738fe746-3518-4830-8137-f29473d7e1a9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11830488","allele":{"id":"https://genegraph.clinicalgenome.org/r/c2089054-1b69-4d99-b052-d6ec11d9cd87","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001754.4(RUNX1):c.861C>A (p.Tyr287Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/14467"}}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/75448ddf-6acc-405e-90a9-38a1ca6d4bef_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A nonsense mutation at amino acid 201 near the 3 ́ end of exon 5.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b642c4e-8975-46e2-a05e-9063e8c51654","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 4","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Direct sequence analysis of exons 1–8 amplified from genomic DNA","firstTestingMethod":"PCR","phenotypes":["obo:HP_0004808","obo:HP_0003540","obo:HP_0002863","obo:HP_0001873"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/75448ddf-6acc-405e-90a9-38a1ca6d4bef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","allele":{"id":"https://genegraph.clinicalgenome.org/r/0aba3270-39dd-4f54-be9a-f22329114030","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001754.4(RUNX1):c.601C>T (p.Arg201Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/376018"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":7.5},{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a719b274-2a6c-4f40-820e-882deeff8da1_proband_score_evidence_line","type":"EvidenceLine","dc:description":"K83E showed no detectable DNA binding in the presence or absence of PEBPb/CBFb on EMSA analyses. K83E mutant proteins showed reduced nuclear localization.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2d8c103-79f4-4534-b6a8-d5d926e868dc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11830488","rdfs:label":"pedigree 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"All 9 exons of RUNX1 were amplified from genomic DNA using primers designed to the flanking region of each exon.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0003540","obo:HP_0004808","obo:HP_0001873","obo:HP_0002863"],"previousTesting":true,"previousTestingDescription":"Previously described in PMID: 1958483.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a719b274-2a6c-4f40-820e-882deeff8da1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11830488","allele":{"id":"https://genegraph.clinicalgenome.org/r/072747e1-85ac-4dde-840c-7b3ad4655d19","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001754.4(RUNX1):c.328A>G (p.Lys110Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/14465"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b3184f6a-53a6-4a29-b128-712835b65f08_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Although the NMR structure shown in this paper is not sufficient, the 2001 Nat Struct Biol paper clearly showed the role of R201 in DNA binding. It therefore can be given default or higher points. PMID: 11276260. R201Q also impaired phosphorylation. PMID: 18695000. (Figure 1E). Therefore, I suggest to give it 1 point.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a796205d-546e-4202-8a9f-08ee7a294efb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 5","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Direct sequence analysis of exons 1–8 amplified from genomic DNA","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002863","obo:HP_0001873","obo:HP_0003540","obo:HP_0004808"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/b3184f6a-53a6-4a29-b128-712835b65f08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","allele":{"id":"https://genegraph.clinicalgenome.org/r/3269e843-ebd2-4acd-b08a-ce1e07ef23c4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001754.4(RUNX1):c.602G>A (p.Arg201Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/14464"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8aad81a5-257b-4d3c-9f5e-7f80e415aded_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Although the NMR structure shown in this paper is not sufficient, the 2001 Nat Struct Biol paper clearly showed the role of R166 in DNA binding. It therefore can be given default points. PMID: 11276260","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f83c87f-36e3-442e-8739-8e1373dbf297","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 6","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Direct sequence analysis of exons 1–8 amplified from genomic DNA","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001873","obo:HP_0002863","obo:HP_0003540","obo:HP_0004808"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/8aad81a5-257b-4d3c-9f5e-7f80e415aded_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","allele":{"id":"https://genegraph.clinicalgenome.org/r/d71b815c-261f-4e21-8848-c092c4b4b2eb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001754.4(RUNX1):c.497G>A (p.Arg166Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/417961"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/06aed341-58db-459b-a750-7142e29b420b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b29d70e-95a1-42eb-947a-3cfff8b7479f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 5","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/8b29d70e-95a1-42eb-947a-3cfff8b7479f","type":"Family","rdfs:label":"pedigree 5","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/a796205d-546e-4202-8a9f-08ee7a294efb"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":9,"phenotypes":["obo:HP_0002863","obo:HP_0004808","obo:HP_0001873","obo:HP_0003540"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a796205d-546e-4202-8a9f-08ee7a294efb"}},{"id":"https://genegraph.clinicalgenome.org/r/ebca887b-64e3-4140-973a-b458528d4f70_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 4","estimatedLodScore":2.71,"family":{"id":"https://genegraph.clinicalgenome.org/r/ebca887b-64e3-4140-973a-b458528d4f70","type":"Family","rdfs:label":"pedigree 4","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9b642c4e-8975-46e2-a05e-9063e8c51654"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":10,"phenotypes":["obo:HP_0002863","obo:HP_0004808","obo:HP_0003540","obo:HP_0001873"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9b642c4e-8975-46e2-a05e-9063e8c51654"}},{"id":"https://genegraph.clinicalgenome.org/r/3bcc64a5-3f5c-4fe7-aa2f-1f006da7a3ff_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 2","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/3bcc64a5-3f5c-4fe7-aa2f-1f006da7a3ff","type":"Family","rdfs:label":"pedigree 2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/04dbb86e-2470-46ba-a353-7b03f9d2e761"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0002863","obo:HP_0001873","obo:HP_0004808","obo:HP_0003540"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/04dbb86e-2470-46ba-a353-7b03f9d2e761"}},{"id":"https://genegraph.clinicalgenome.org/r/5829625c-7434-4544-b083-934d489175fd_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11830488","rdfs:label":"pedigree 2","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/5829625c-7434-4544-b083-934d489175fd","type":"Family","rdfs:label":"pedigree 2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/4c93f1c1-c4e3-4aa3-a18e-8752418f814c"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":9,"phenotypes":["obo:HP_0002863","obo:HP_0003540","obo:HP_0001873","obo:HP_0004808"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/4c93f1c1-c4e3-4aa3-a18e-8752418f814c"}},{"id":"https://genegraph.clinicalgenome.org/r/668bbd52-6d81-4545-99d6-75e02c246d97_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 1","estimatedLodScore":8.43,"family":{"id":"https://genegraph.clinicalgenome.org/r/668bbd52-6d81-4545-99d6-75e02c246d97","type":"Family","rdfs:label":"pedigree 1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"}},"meetsInclusionCriteria":true,"phenotype":[{"id":"obo:HP_0004808"},{"id":"obo:HP_0003540"},{"id":"obo:HP_0002863"},{"id":"obo:HP_0001873"}],"phenotypeFreeText":"","phenotypePositiveAllelePositive":29},{"id":"https://genegraph.clinicalgenome.org/r/e69e91f0-841d-49f2-b199-2fc1da2d1b1a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11830488","rdfs:label":"pedigree 3","estimatedLodScore":3.91,"family":{"id":"https://genegraph.clinicalgenome.org/r/e69e91f0-841d-49f2-b199-2fc1da2d1b1a","type":"Family","rdfs:label":"pedigree 3","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7545ecc5-13f8-4c70-8dd1-34a7c547a56a"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":13,"phenotypes":["obo:HP_0004808","obo:HP_0001873","obo:HP_0002863","obo:HP_0003540"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7545ecc5-13f8-4c70-8dd1-34a7c547a56a"}},{"id":"https://genegraph.clinicalgenome.org/r/891db2fd-27f0-4e3d-a066-92c879a47076_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 3","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/891db2fd-27f0-4e3d-a066-92c879a47076","type":"Family","rdfs:label":"pedigree 3","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9e89eb9d-65d5-4820-a2a1-102bc3b9e2f4"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":9,"phenotypes":["obo:HP_0001873","obo:HP_0003540","obo:HP_0002863","obo:HP_0004808"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9e89eb9d-65d5-4820-a2a1-102bc3b9e2f4"}},{"id":"https://genegraph.clinicalgenome.org/r/0015ac4f-5935-480d-a702-e580ea70df5c_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11830488","rdfs:label":"pedigree 1","estimatedLodScore":3.91,"family":{"id":"https://genegraph.clinicalgenome.org/r/0015ac4f-5935-480d-a702-e580ea70df5c","type":"Family","rdfs:label":"pedigree 1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b2d8c103-79f4-4534-b6a8-d5d926e868dc"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":14,"phenotypes":["obo:HP_0002863","obo:HP_0003540","obo:HP_0004808","obo:HP_0001873"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b2d8c103-79f4-4534-b6a8-d5d926e868dc"}},{"id":"https://genegraph.clinicalgenome.org/r/b50f17ad-109a-4293-87bc-bf5fd16fadd7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508512","rdfs:label":"pedigree 6","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/b50f17ad-109a-4293-87bc-bf5fd16fadd7","type":"Family","rdfs:label":"pedigree 6","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6f83c87f-36e3-442e-8739-8e1373dbf297"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0003540","obo:HP_0004808","obo:HP_0001873","obo:HP_0002863"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6f83c87f-36e3-442e-8739-8e1373dbf297"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":651,"specifiedBy":"GeneValidityCriteria5","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/8-zjecJe910","type":"GeneValidityProposition","disease":"obo:MONDO_0011071","gene":"hgnc:10471","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_06aed341-58db-459b-a750-7142e29b420b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}